WPI 339 (Diclofenac sodium delayed release 75 mg)

Pill imprint WPI 339 has been identified as Diclofenac sodium delayed release 75 mg.

Diclofenac is used in the treatment of back pain; sciatica; frozen shoulder; ankylosing spondylitis; pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 75 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 339

Diclofenac sodium delayed release 75 mg WPI 339
Diclofenac sodium delayed release 75 mg WPI 339
Diclofenac sodium delayed release
Imprint:
WPI 339
Strength:
75 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0339

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)